Lars Bode, PhD
Intestinal and Milk Glycan Expression in Restriction of Neonatal Infection $67,214
R01 AI10510 /NIH/NIAID July 2013-June 2018
Human Milk Screening $232,569
Abbott Nutrition Nov. 2011-Nov. 2014
Effect of Oligosaccharide on Epithelial Cell Biology $27,769
Friesland Campina Domo Dec. 2012-Feb. 2014
Galactooligosaccharide in the Prevention of Amebiasis $10,000
UCSD Academic Senate Grant Apr. 2013-Mar. 2014
Donna M. Garey, MD, MPH High Risk Infant Follow-up Program Request for Health Care Services Application $291,495
11-001/California Department of July 2011-June 2014
Farhad Imam, MD, PhD
Children’s Hospital Real-time Visualization of Central Venous Catheter $100,000
Boston Technology Dev. 2010-2013
Trans-Illumination Of Visible Light For Real-Time Catheter Visualization $298,790
IR43CA162857-01A1/NIH/NCI SBIR 2011-2013
Lawrence (Lance) Prince, MD, PhD
Role of Fetal Lung Macrophages in Bronchopulmonary Institute Dysplasia $307,128
1R01HL097195/ National Heart, Lung, and Blood Institute July 2009-June 2014
Imaging Activated Macrophages in the Lungs $17,393
1R01HL116358-01/National Heart, Lung, and Blood Institute Sept. 2012-Aug. 2015
FGF-10 Expression in a Fetal Mouse Lung Model of Bronchopulmonary Dysplasia $1,726,870
IR01HL086324/ National Heart, Lung, and Blood Institute Apr. 2008-Feb. 2013
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt (IMPROV) $2,406,780
IU01HL101456-01/National Heart, Lung, and Blood Institute May 2010-Apr. 2015
Evan Y. Snyder, MD, PhD
Collaborative Laboratory for Human Embryonic Stem Cell Research $3,457,086
at Sanford-Burnham Medical Research Institute Feb. 2008-Jan. 2015
CL1-00511/California Institute for Regenerative Medicine
La Jolla Parkinson’s Disease Center: A Developmental Health Science $630,049
Perspective to Nitrosative/Oxidative Susceptibility Sept. 2008-June 2013
5 P01 ES016738/National Institute of Environment
Neonatal Brain Ischemia: Neuroimaging as a Basis for Rational Stem Cell Therapy $272,687
R01 NS059770/National Institute of Neurological Diseases & Stroke Mar. 2009-Feb. 2013
Patient-derived Stem Cells for Phosphoproteomic Profiling Neuropsychopathology $1,838,410
RC2 MH090011/NIH Sept. 2010-Aug. 2012
Development and Characterization of a standardized Adult Mesenchymal Stem $250,000
Cell Source for Therapeutic and Research Oct. 2012-Apr. 2014
RB3-06276/CSRA 13-05/Scharp/Prodo Technologies
Establishing & characterizing hiPSCs from patients with neuropsychiatric disorders $245,700
JJ-OPCO-WO#11/Johnson & Johnson July 2011-June 2013
Establish a Stem Cell-based In Vitro Model of Bipolar Disorder to Study $100,000
Basic Underlying Disease Mechanisms Jan. 2009-June 2013
California Bipolar Foundation
Homing of Stem Cells in Stroke Therapeutics $523,889
R21 NS062428/National Institute of Neurological Diseases and Stroke June 2009-Feb. 2012
To establish hiPSCs from lithium-responsive bipolar patients & determine $500,000
pathophysiological mechanisms & potential drug targets July 2012-June 2014
Viterbi Foundation
To Establish a Stem Cell-Based In Vitro Model of Bipolar Disorder to $26,000
Study Basic Underlying Disease Mechanism May 2010-June 2013
Parkinson’s Disease Association of San Diego
The Therapeutic Potential of Human Induced Pluripotent Stem Cells (IPSCs) $250,000
in the Sandhoff Disease Mouse Model of Lysosomal Storage Disorders Aug. 2011-July 2013
National Tay-Sachs & Allied Diseases Foundation